Pharmaceutical News

RSS

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.

4 Dec 2019

Common drug for nerve pain could help restore upper limb function after spinal cord injury

Long-term treatment with gabapentin, a commonly prescribed drug for nerve pain, could help restore upper limb function after a spinal cord injury, new research in mice suggests.

3 Dec 2019

New PA program in Massachusetts to provide knowledge, skills to prescribe opiates safely

Morbidity and mortality from prescription and synthetic opioid use and abuse continues to be a U.S. public health issue. In an effort to help curtail this crisis, researchers from Boston University School of Medicine describe an approach to ensure Physician Assistant (PA) students graduating from any PA program in Massachusetts will have the knowledge and skills to prescribe opiates safely.

3 Dec 2019

Aspirin can be considered an effective and safe option to treat acute migraines

According to a new report in The American Journal of Medicine, published by Elsevier, aspirin can be considered an effective and safe option to other, more expensive medications to treat acute migraines as well as prevent recurrent attacks.

3 Dec 2019

Multiple mechanisms at work in diabetes drug metformin

Metformin is the most commonly prescribed type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. In a collaborative effort, researchers from the Salk Institute, The Scripps Research Institute and Weill Cornell Medical College have used a novel technology to investigate why it functions so well.

3 Dec 2019

Researchers propose aspirin as possible treatment option for patients with migraine

Migraine headache is the third most common disease in the world affecting about 1 in 7 people. More prevalent than diabetes, epilepsy and asthma combined, migraine headaches are among the most common and potentially debilitating disorders encountered by primary health care providers.

3 Dec 2019

Study finds it may be possible to treat endometriosis using an investigational cancer drug

Researchers have shown that painful endometriosis symptoms could be alleviated using an investigational cancer drug.

3 Dec 2019

Failure to ensure environmental management of pharmaceuticals can lead to adverse outcomes

Poor sanitation leads to untreated wastewater entering river systems in many countries where industrialisation and urbanisation is not supported by appropriate infrastructure.

3 Dec 2019

Study reveals three effective treatments to stop epilepsy seizures

There are effective treatments to stop life-threatening epilepsy seizures when the initial treatment has failed, a sweeping new study reveals.

3 Dec 2019

New HIV drug combo rolled out in South Africa

South Africa has started distribution of the new anti-retroviral pill that combines three drugs to combat the HIV menace. The distribution began Sunday 1st of December 2019, to mark the World AIDS Day.

2 Dec 2019

Painful endometriosis symptoms could be reduced with a cancer drug

The painful symptoms of endometriosis - a chronic condition which affects millions of women - could potentially be reduced with a drug that had previously been investigated as a cancer treatment.

2 Dec 2019

New treatment could make passing kidney stones faster and less painful

Every year, more than half a million Americans visit the emergency room for kidney stone problems. In most cases, the stones eventually pass out of the body on their own, but the process can be excruciatingly painful.

2 Dec 2019

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

2 Dec 2019

New medicine could reduce number of infants dying from AIDS

A new, strawberry-flavored, granule-form medicine may be a solution for treating infants with AIDs.

2 Dec 2019

New medicine could reduce number of infant deaths from AIDS

A new, strawberry-flavored, granule-form medicine may be a solution for treating infants with AIDs.

2 Dec 2019

Comparative study finds three anti-seizure drugs to be equally safe and effective

A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective.

27 Nov 2019

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

The popular heartburn drug ranitidine, commonly known as Zantac, was voluntarily recalled due to the contamination of a human carcinogen that could potentially cause cancer. The recall includes oral tablets, capsules, and syrup.

27 Nov 2019

Some antiarrhythmic medications for AFib less effective in obese patients

Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity and AFib, the underlying mechanism of how obesity contributes to the heart arrhythmia is still unknown.

27 Nov 2019

Geospatial model helps compare costs of different anticoagulant therapies

Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation. A new study from the University of Eastern Finland shows that direct oral anticoagulants can be a more cost-effective alternative than traditional warfarin therapy when the patient's place of residence is taken into consideration.

27 Nov 2019

FDA-approved anti-inflammatory drug delays onset of ALS in mice

The cause of amyotrophic lateral sclerosis (ALS)--a disabling neurodegenerative disease that affects nerve cells in the brain and spinal cord and leads to weakened muscles and early death--is not fully understood, but accumulating evidence suggests that inflammatory processes may play a role in the initiation and progression of the condition.

27 Nov 2019

Pharmaceutical News

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Common drug for nerve pain could help restore upper limb function after spinal cord injury

New PA program in Massachusetts to provide knowledge, skills to prescribe opiates safely

Aspirin can be considered an effective and safe option to treat acute migraines

Multiple mechanisms at work in diabetes drug metformin

Researchers propose aspirin as possible treatment option for patients with migraine

Study finds it may be possible to treat endometriosis using an investigational cancer drug

Failure to ensure environmental management of pharmaceuticals can lead to adverse outcomes

Study reveals three effective treatments to stop epilepsy seizures

New HIV drug combo rolled out in South Africa

Painful endometriosis symptoms could be reduced with a cancer drug

New treatment could make passing kidney stones faster and less painful

Consortium launches ambitious project to transform the treatment of pain

New medicine could reduce number of infants dying from AIDS

New medicine could reduce number of infant deaths from AIDS

Comparative study finds three anti-seizure drugs to be equally safe and effective

Popular heartburn drug voluntarily recalled for carcinogen levels above FDA standards

Some antiarrhythmic medications for AFib less effective in obese patients

Geospatial model helps compare costs of different anticoagulant therapies

FDA-approved anti-inflammatory drug delays onset of ALS in mice

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Latest News